http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102884084-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-734 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2011-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102884084-B |
| titleOfInvention | Anti-HER 2 and compositions |
| abstract | The present invention relates to novel HER2 (ErbB2) targeted therapeutic antibody and anti-HER2 recombinant polyclonal antibody compositions, and this antibody and antibody compositions are used for treating the purposes of cancer.Described antibody compositions comprises the recombinant antibodies that at least three kinds of epi-positions different from HER2 combine.The HER2 of two of which antibodies cell surface, causes them to produce the antibody receptor grid of crosslinking at cell surface, and therefore causes HER2 receptor internalisation.The third antibodies HER2 in compositions, therefore it block the different dimerization between HER2 and HER3. |
| priorityDate | 2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 190.